Aeon Global Health Corp.
Aeon Global Health Corp. AGHC Peers
See (AGHC) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AGHC | $0.00 | N/A | 0 | N/A | N/A | N/A |
| LZAGY | $68.17 | -0.05% | 49.2B | 61.97 | $1.10 | +0.76% |
| LZAGF | $673.00 | -1.64% | 47.3B | 61.46 | $10.95 | +0.43% |
| WUXAY | $9.39 | -0.74% | 26.6B | 17.39 | $0.54 | +0.48% |
| WUXIF | $7.34 | N/A | 19.6B | 13.59 | $0.54 | +0.65% |
| BMXMF | $142.45 | N/A | 16.8B | 33.92 | $4.20 | +0.69% |
| ERFSF | $70.25 | -0.87% | 12.4B | 29.15 | $2.41 | +1.51% |
| SKHCF | $17.91 | +10.28% | 8.6B | 24.20 | $0.74 | +3.92% |
| SKHHY | $17.10 | -2.29% | 8.2B | 23.11 | $0.74 | +3.92% |
| DSRLF | $107.68 | -0.90% | 5.8B | 27.19 | $3.96 | +1.29% |
Stock Comparison
AGHC vs LZAGY Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, LZAGY has a market cap of 49.2B. Regarding current trading prices, AGHC is priced at $0.00, while LZAGY trades at $68.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas LZAGY's P/E ratio is 61.97. In terms of profitability, AGHC's ROE is +2.90%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, AGHC is less volatile compared to LZAGY. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs LZAGF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, LZAGF has a market cap of 47.3B. Regarding current trading prices, AGHC is priced at $0.00, while LZAGF trades at $673.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas LZAGF's P/E ratio is 61.46. In terms of profitability, AGHC's ROE is +2.90%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, AGHC and LZAGF have similar daily volatility (0.00).
AGHC vs WUXAY Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, WUXAY has a market cap of 26.6B. Regarding current trading prices, AGHC is priced at $0.00, while WUXAY trades at $9.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas WUXAY's P/E ratio is 17.39. In terms of profitability, AGHC's ROE is +2.90%, compared to WUXAY's ROE of +0.19%. Regarding short-term risk, AGHC and WUXAY have similar daily volatility (0.00).
AGHC vs WUXIF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, WUXIF has a market cap of 19.6B. Regarding current trading prices, AGHC is priced at $0.00, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas WUXIF's P/E ratio is 13.59. In terms of profitability, AGHC's ROE is +2.90%, compared to WUXIF's ROE of +0.19%. Regarding short-term risk, AGHC and WUXIF have similar daily volatility (0.00).
AGHC vs BMXMF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, BMXMF has a market cap of 16.8B. Regarding current trading prices, AGHC is priced at $0.00, while BMXMF trades at $142.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas BMXMF's P/E ratio is 33.92. In terms of profitability, AGHC's ROE is +2.90%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, AGHC is less volatile compared to BMXMF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs ERFSF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, ERFSF has a market cap of 12.4B. Regarding current trading prices, AGHC is priced at $0.00, while ERFSF trades at $70.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas ERFSF's P/E ratio is 29.15. In terms of profitability, AGHC's ROE is +2.90%, compared to ERFSF's ROE of +0.07%. Regarding short-term risk, AGHC is less volatile compared to ERFSF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs SKHCF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, SKHCF has a market cap of 8.6B. Regarding current trading prices, AGHC is priced at $0.00, while SKHCF trades at $17.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas SKHCF's P/E ratio is 24.20. In terms of profitability, AGHC's ROE is +2.90%, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, AGHC and SKHCF have similar daily volatility (0.00).
AGHC vs SKHHY Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, SKHHY has a market cap of 8.2B. Regarding current trading prices, AGHC is priced at $0.00, while SKHHY trades at $17.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas SKHHY's P/E ratio is 23.11. In terms of profitability, AGHC's ROE is +2.90%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, AGHC is less volatile compared to SKHHY. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs DSRLF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, DSRLF has a market cap of 5.8B. Regarding current trading prices, AGHC is priced at $0.00, while DSRLF trades at $107.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas DSRLF's P/E ratio is 27.19. In terms of profitability, AGHC's ROE is +2.90%, compared to DSRLF's ROE of +0.09%. Regarding short-term risk, AGHC and DSRLF have similar daily volatility (0.00).
AGHC vs HNGZY Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, HNGZY has a market cap of 5.7B. Regarding current trading prices, AGHC is priced at $0.00, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, AGHC's ROE is +2.90%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, AGHC and HNGZY have similar daily volatility (0.00).
AGHC vs VIMGF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, VIMGF has a market cap of 2.3B. Regarding current trading prices, AGHC is priced at $0.00, while VIMGF trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas VIMGF's P/E ratio is 90.00. In terms of profitability, AGHC's ROE is +2.90%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, AGHC and VIMGF have similar daily volatility (0.00).
AGHC vs MRCHF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, MRCHF has a market cap of 1.2B. Regarding current trading prices, AGHC is priced at $0.00, while MRCHF trades at $20.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas MRCHF's P/E ratio is 61.59. In terms of profitability, AGHC's ROE is +2.90%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, AGHC is less volatile compared to MRCHF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs IDGXF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, IDGXF has a market cap of 186M. Regarding current trading prices, AGHC is priced at $0.00, while IDGXF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas IDGXF's P/E ratio is 8.00. In terms of profitability, AGHC's ROE is +2.90%, compared to IDGXF's ROE of +0.24%. Regarding short-term risk, AGHC is less volatile compared to IDGXF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs EDTXF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, EDTXF has a market cap of 174.1M. Regarding current trading prices, AGHC is priced at $0.00, while EDTXF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas EDTXF's P/E ratio is -10.17. In terms of profitability, AGHC's ROE is +2.90%, compared to EDTXF's ROE of +0.79%. Regarding short-term risk, AGHC is less volatile compared to EDTXF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs AMCY Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, AMCY has a market cap of 171.3M. Regarding current trading prices, AGHC is priced at $0.00, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas AMCY's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to AMCY's ROE of N/A. Regarding short-term risk, AGHC and AMCY have similar daily volatility (0.00).
AGHC vs NNGRF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, NNGRF has a market cap of 164.3M. Regarding current trading prices, AGHC is priced at $0.00, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, AGHC's ROE is +2.90%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, AGHC and NNGRF have similar daily volatility (0.00).
AGHC vs CORBF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, CORBF has a market cap of 158M. Regarding current trading prices, AGHC is priced at $0.00, while CORBF trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas CORBF's P/E ratio is 3.37. In terms of profitability, AGHC's ROE is +2.90%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, AGHC and CORBF have similar daily volatility (0.00).
AGHC vs THOXF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, THOXF has a market cap of 130.9M. Regarding current trading prices, AGHC is priced at $0.00, while THOXF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas THOXF's P/E ratio is -14.40. In terms of profitability, AGHC's ROE is +2.90%, compared to THOXF's ROE of -0.91%. Regarding short-term risk, AGHC is less volatile compared to THOXF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs DIUXF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, DIUXF has a market cap of 115.5M. Regarding current trading prices, AGHC is priced at $0.00, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, AGHC's ROE is +2.90%, compared to DIUXF's ROE of -0.07%. Regarding short-term risk, AGHC and DIUXF have similar daily volatility (0.00).
AGHC vs TIHE Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, TIHE has a market cap of 71.9M. Regarding current trading prices, AGHC is priced at $0.00, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas TIHE's P/E ratio is 0.32. In terms of profitability, AGHC's ROE is +2.90%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, AGHC and TIHE have similar daily volatility (0.00).
AGHC vs BIOGF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, BIOGF has a market cap of 65.4M. Regarding current trading prices, AGHC is priced at $0.00, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, AGHC's ROE is +2.90%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, AGHC and BIOGF have similar daily volatility (0.00).
AGHC vs PCNEF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, PCNEF has a market cap of 62M. Regarding current trading prices, AGHC is priced at $0.00, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, AGHC's ROE is +2.90%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, AGHC and PCNEF have similar daily volatility (0.00).
AGHC vs ANPCF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, ANPCF has a market cap of 51.9M. Regarding current trading prices, AGHC is priced at $0.00, while ANPCF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas ANPCF's P/E ratio is -1.61. In terms of profitability, AGHC's ROE is +2.90%, compared to ANPCF's ROE of -0.54%. Regarding short-term risk, AGHC and ANPCF have similar daily volatility (0.00).
AGHC vs PFGTF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, PFGTF has a market cap of 50.6M. Regarding current trading prices, AGHC is priced at $0.00, while PFGTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas PFGTF's P/E ratio is -3.11. In terms of profitability, AGHC's ROE is +2.90%, compared to PFGTF's ROE of -0.41%. Regarding short-term risk, AGHC is less volatile compared to PFGTF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs CLIFF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, CLIFF has a market cap of 44.1M. Regarding current trading prices, AGHC is priced at $0.00, while CLIFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas CLIFF's P/E ratio is -2.87. In terms of profitability, AGHC's ROE is +2.90%, compared to CLIFF's ROE of -0.08%. Regarding short-term risk, AGHC is less volatile compared to CLIFF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs BIOQ Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, BIOQ has a market cap of 39.6M. Regarding current trading prices, AGHC is priced at $0.00, while BIOQ trades at $44.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas BIOQ's P/E ratio is 15.86. In terms of profitability, AGHC's ROE is +2.90%, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, AGHC is less volatile compared to BIOQ. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs SNANF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, SNANF has a market cap of 33.4M. Regarding current trading prices, AGHC is priced at $0.00, while SNANF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas SNANF's P/E ratio is -15.42. In terms of profitability, AGHC's ROE is +2.90%, compared to SNANF's ROE of -2.51%. Regarding short-term risk, AGHC is less volatile compared to SNANF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs ANPCY Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, ANPCY has a market cap of 28.9M. Regarding current trading prices, AGHC is priced at $0.00, while ANPCY trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas ANPCY's P/E ratio is -1.38. In terms of profitability, AGHC's ROE is +2.90%, compared to ANPCY's ROE of -0.75%. Regarding short-term risk, AGHC and ANPCY have similar daily volatility (0.00).
AGHC vs IMMVF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, IMMVF has a market cap of 22.6M. Regarding current trading prices, AGHC is priced at $0.00, while IMMVF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas IMMVF's P/E ratio is -0.32. In terms of profitability, AGHC's ROE is +2.90%, compared to IMMVF's ROE of -2.69%. Regarding short-term risk, AGHC is less volatile compared to IMMVF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs BMKDF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, BMKDF has a market cap of 21.1M. Regarding current trading prices, AGHC is priced at $0.00, while BMKDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas BMKDF's P/E ratio is -23.18. In terms of profitability, AGHC's ROE is +2.90%, compared to BMKDF's ROE of +2.24%. Regarding short-term risk, AGHC is less volatile compared to BMKDF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs VILGF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, VILGF has a market cap of 20.7M. Regarding current trading prices, AGHC is priced at $0.00, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas VILGF's P/E ratio is -0.30. In terms of profitability, AGHC's ROE is +2.90%, compared to VILGF's ROE of N/A. Regarding short-term risk, AGHC and VILGF have similar daily volatility (0.00).
AGHC vs PCHM Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, PCHM has a market cap of 17.8M. Regarding current trading prices, AGHC is priced at $0.00, while PCHM trades at $3.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas PCHM's P/E ratio is -0.02. In terms of profitability, AGHC's ROE is +2.90%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, AGHC is less volatile compared to PCHM. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs LDXHF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, LDXHF has a market cap of 15M. Regarding current trading prices, AGHC is priced at $0.00, while LDXHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas LDXHF's P/E ratio is -2.00. In terms of profitability, AGHC's ROE is +2.90%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, AGHC and LDXHF have similar daily volatility (0.00).
AGHC vs ABDXF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, ABDXF has a market cap of 13.6M. Regarding current trading prices, AGHC is priced at $0.00, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, AGHC's ROE is +2.90%, compared to ABDXF's ROE of -0.63%. Regarding short-term risk, AGHC and ABDXF have similar daily volatility (0.00).
AGHC vs IZOZF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, IZOZF has a market cap of 12.2M. Regarding current trading prices, AGHC is priced at $0.00, while IZOZF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas IZOZF's P/E ratio is -6.72. In terms of profitability, AGHC's ROE is +2.90%, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, AGHC is less volatile compared to IZOZF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs PMSNF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, PMSNF has a market cap of 11.8M. Regarding current trading prices, AGHC is priced at $0.00, while PMSNF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas PMSNF's P/E ratio is -2.00. In terms of profitability, AGHC's ROE is +2.90%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, AGHC is less volatile compared to PMSNF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs MXDHF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, MXDHF has a market cap of 8.6M. Regarding current trading prices, AGHC is priced at $0.00, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, AGHC's ROE is +2.90%, compared to MXDHF's ROE of -6.91%. Regarding short-term risk, AGHC and MXDHF have similar daily volatility (0.00).
AGHC vs VRCDF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, VRCDF has a market cap of 7.3M. Regarding current trading prices, AGHC is priced at $0.00, while VRCDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas VRCDF's P/E ratio is -1.00. In terms of profitability, AGHC's ROE is +2.90%, compared to VRCDF's ROE of -0.73%. Regarding short-term risk, AGHC is less volatile compared to VRCDF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs SQIDF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, SQIDF has a market cap of 6.1M. Regarding current trading prices, AGHC is priced at $0.00, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, AGHC's ROE is +2.90%, compared to SQIDF's ROE of +4.47%. Regarding short-term risk, AGHC is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs TDSGF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, TDSGF has a market cap of 5.4M. Regarding current trading prices, AGHC is priced at $0.00, while TDSGF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas TDSGF's P/E ratio is -2.69. In terms of profitability, AGHC's ROE is +2.90%, compared to TDSGF's ROE of -3.19%. Regarding short-term risk, AGHC and TDSGF have similar daily volatility (0.00).
AGHC vs SLDX Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, SLDX has a market cap of 4.8M. Regarding current trading prices, AGHC is priced at $0.00, while SLDX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas SLDX's P/E ratio is -0.01. In terms of profitability, AGHC's ROE is +2.90%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, AGHC is less volatile compared to SLDX. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs RNVA Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, RNVA has a market cap of 4.3M. Regarding current trading prices, AGHC is priced at $0.00, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas RNVA's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, AGHC and RNVA have similar daily volatility (0.00).
AGHC vs JMPHF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, JMPHF has a market cap of 4.2M. Regarding current trading prices, AGHC is priced at $0.00, while JMPHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas JMPHF's P/E ratio is -0.91. In terms of profitability, AGHC's ROE is +2.90%, compared to JMPHF's ROE of -0.11%. Regarding short-term risk, AGHC is less volatile compared to JMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs AVCRF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, AVCRF has a market cap of 3.9M. Regarding current trading prices, AGHC is priced at $0.00, while AVCRF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas AVCRF's P/E ratio is -3.85. In terms of profitability, AGHC's ROE is +2.90%, compared to AVCRF's ROE of +0.05%. Regarding short-term risk, AGHC and AVCRF have similar daily volatility (0.00).
AGHC vs GNTLF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, GNTLF has a market cap of 3.7M. Regarding current trading prices, AGHC is priced at $0.00, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, AGHC's ROE is +2.90%, compared to GNTLF's ROE of -3.62%. Regarding short-term risk, AGHC and GNTLF have similar daily volatility (0.00).
AGHC vs SZLSF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, SZLSF has a market cap of 3.5M. Regarding current trading prices, AGHC is priced at $0.00, while SZLSF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas SZLSF's P/E ratio is -0.24. In terms of profitability, AGHC's ROE is +2.90%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, AGHC is less volatile compared to SZLSF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs IDXG Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, IDXG has a market cap of 3.4M. Regarding current trading prices, AGHC is priced at $0.00, while IDXG trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas IDXG's P/E ratio is 2.75. In terms of profitability, AGHC's ROE is +2.90%, compared to IDXG's ROE of -1.19%. Regarding short-term risk, AGHC and IDXG have similar daily volatility (0.00).
AGHC vs ICBU Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, ICBU has a market cap of 2.5M. Regarding current trading prices, AGHC is priced at $0.00, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas ICBU's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, AGHC and ICBU have similar daily volatility (0.00).
AGHC vs IBXXF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, IBXXF has a market cap of 1.6M. Regarding current trading prices, AGHC is priced at $0.00, while IBXXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas IBXXF's P/E ratio is -0.27. In terms of profitability, AGHC's ROE is +2.90%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, AGHC is less volatile compared to IBXXF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs IVRO Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, IVRO has a market cap of 1.4M. Regarding current trading prices, AGHC is priced at $0.00, while IVRO trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas IVRO's P/E ratio is -0.75. In terms of profitability, AGHC's ROE is +2.90%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, AGHC is less volatile compared to IVRO. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs IDTA Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, IDTA has a market cap of 1.3M. Regarding current trading prices, AGHC is priced at $0.00, while IDTA trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas IDTA's P/E ratio is 3.30. In terms of profitability, AGHC's ROE is +2.90%, compared to IDTA's ROE of +0.36%. Regarding short-term risk, AGHC and IDTA have similar daily volatility (0.00).
AGHC vs NSTM Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, NSTM has a market cap of 1.2M. Regarding current trading prices, AGHC is priced at $0.00, while NSTM trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas NSTM's P/E ratio is -0.44. In terms of profitability, AGHC's ROE is +2.90%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, AGHC is less volatile compared to NSTM. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs DIGP Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, DIGP has a market cap of 1.1M. Regarding current trading prices, AGHC is priced at $0.00, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas DIGP's P/E ratio is -1.04. In terms of profitability, AGHC's ROE is +2.90%, compared to DIGP's ROE of +3.08%. Regarding short-term risk, AGHC is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs SCRSF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, SCRSF has a market cap of 910.6K. Regarding current trading prices, AGHC is priced at $0.00, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas SCRSF's P/E ratio is -0.09. In terms of profitability, AGHC's ROE is +2.90%, compared to SCRSF's ROE of +2.91%. Regarding short-term risk, AGHC and SCRSF have similar daily volatility (0.00).
AGHC vs EPGNF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, EPGNF has a market cap of 692.8K. Regarding current trading prices, AGHC is priced at $0.00, while EPGNF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas EPGNF's P/E ratio is -0.04. In terms of profitability, AGHC's ROE is +2.90%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, AGHC is less volatile compared to EPGNF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs MBGNF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, MBGNF has a market cap of 172.6K. Regarding current trading prices, AGHC is priced at $0.00, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas MBGNF's P/E ratio is -1.00. In terms of profitability, AGHC's ROE is +2.90%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, AGHC and MBGNF have similar daily volatility (0.00).
AGHC vs NVTAQ Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, NVTAQ has a market cap of 85.9K. Regarding current trading prices, AGHC is priced at $0.00, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, AGHC's ROE is +2.90%, compared to NVTAQ's ROE of +0.00%. Regarding short-term risk, AGHC is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs HCLC Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, HCLC has a market cap of 74K. Regarding current trading prices, AGHC is priced at $0.00, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas HCLC's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, AGHC and HCLC have similar daily volatility (0.00).
AGHC vs MEDVF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, MEDVF has a market cap of 54K. Regarding current trading prices, AGHC is priced at $0.00, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, AGHC's ROE is +2.90%, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, AGHC and MEDVF have similar daily volatility (0.00).
AGHC vs CHHL Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, CHHL has a market cap of 37.3K. Regarding current trading prices, AGHC is priced at $0.00, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas CHHL's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to CHHL's ROE of +0.00%. Regarding short-term risk, AGHC is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs IHTI Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, IHTI has a market cap of 32.5K. Regarding current trading prices, AGHC is priced at $0.00, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas IHTI's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, AGHC is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs MEDD Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, MEDD has a market cap of 31.9K. Regarding current trading prices, AGHC is priced at $0.00, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas MEDD's P/E ratio is -0.01. In terms of profitability, AGHC's ROE is +2.90%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, AGHC and MEDD have similar daily volatility (0.00).
AGHC vs TOMDF Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, TOMDF has a market cap of 14.1K. Regarding current trading prices, AGHC is priced at $0.00, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas TOMDF's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, AGHC is less volatile compared to TOMDF. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs CGNH Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, CGNH has a market cap of 12K. Regarding current trading prices, AGHC is priced at $0.00, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas CGNH's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, AGHC is less volatile compared to CGNH. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs RSHN Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, RSHN has a market cap of 8.2K. Regarding current trading prices, AGHC is priced at $0.00, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas RSHN's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, AGHC and RSHN have similar daily volatility (0.00).
AGHC vs ABMC Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, ABMC has a market cap of 4.8K. Regarding current trading prices, AGHC is priced at $0.00, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas ABMC's P/E ratio is 0.01. In terms of profitability, AGHC's ROE is +2.90%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, AGHC and ABMC have similar daily volatility (0.00).
AGHC vs RGDXQ Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, RGDXQ has a market cap of 3.9K. Regarding current trading prices, AGHC is priced at $0.00, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, AGHC is less volatile compared to RGDXQ. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs DMTKQ Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, DMTKQ has a market cap of 3.5K. Regarding current trading prices, AGHC is priced at $0.00, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to DMTKQ's ROE of -0.80%. Regarding short-term risk, AGHC and DMTKQ have similar daily volatility (0.00).
AGHC vs GWHP Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, GWHP has a market cap of 1.3K. Regarding current trading prices, AGHC is priced at $0.00, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas GWHP's P/E ratio is -0.00. In terms of profitability, AGHC's ROE is +2.90%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, AGHC is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs CYPS Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, CYPS has a market cap of 811. Regarding current trading prices, AGHC is priced at $0.00, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas CYPS's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to CYPS's ROE of N/A. Regarding short-term risk, AGHC is less volatile compared to CYPS. This indicates potentially lower risk in terms of short-term price fluctuations for AGHC.
AGHC vs ARYC Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, ARYC has a market cap of 793. Regarding current trading prices, AGHC is priced at $0.00, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas ARYC's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, AGHC and ARYC have similar daily volatility (0.00).
AGHC vs ROSGQ Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, ROSGQ has a market cap of 593. Regarding current trading prices, AGHC is priced at $0.00, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, AGHC and ROSGQ have similar daily volatility (0.00).
AGHC vs BIOCQ Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, BIOCQ has a market cap of 263. Regarding current trading prices, AGHC is priced at $0.00, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas BIOCQ's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, AGHC and BIOCQ have similar daily volatility (0.00).
AGHC vs HTGMQ Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, HTGMQ has a market cap of 221. Regarding current trading prices, AGHC is priced at $0.00, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, AGHC and HTGMQ have similar daily volatility (0.00).
AGHC vs OPGX Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, OPGX has a market cap of 17. Regarding current trading prices, AGHC is priced at $0.00, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas OPGX's P/E ratio is -0.17. In terms of profitability, AGHC's ROE is +2.90%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, AGHC and OPGX have similar daily volatility (0.00).
AGHC vs MRPS Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, MRPS has a market cap of 0. Regarding current trading prices, AGHC is priced at $0.00, while MRPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas MRPS's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to MRPS's ROE of N/A. Regarding short-term risk, AGHC and MRPS have similar daily volatility (0.00).
AGHC vs EPGNY Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, EPGNY has a market cap of 0. Regarding current trading prices, AGHC is priced at $0.00, while EPGNY trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas EPGNY's P/E ratio is -1.60. In terms of profitability, AGHC's ROE is +2.90%, compared to EPGNY's ROE of -0.19%. Regarding short-term risk, AGHC and EPGNY have similar daily volatility (0.00).
AGHC vs BGNX Comparison
AGHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGHC stands at 0. In comparison, BGNX has a market cap of 0. Regarding current trading prices, AGHC is priced at $0.00, while BGNX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGHC currently has a P/E ratio of N/A, whereas BGNX's P/E ratio is N/A. In terms of profitability, AGHC's ROE is +2.90%, compared to BGNX's ROE of N/A. Regarding short-term risk, AGHC and BGNX have similar daily volatility (0.00).